Barclays PLC Nuvasive Inc Transaction History

Barclays PLC

  • $288 Billion
  • Q1 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023
BUY
$36.71 - $44.15 $573,814 - $690,108
15,631 Added 14.0%
127,283 $5.29 Million
Q1 2023

May 04, 2023
BUY
$36.81 - $48.12 $887,231 - $1.16 Million
24,103 Added 27.53%
111,652 $4.61 Million
Q4 2022

Feb 13, 2023
SELL
$35.68 - $44.71 $2.85 Million - $3.57 Million
-79,738 Reduced 47.67%
87,549 $3.61 Million
Q3 2022

Nov 03, 2022
SELL
$42.51 - $54.02 $30.8 Million - $39.1 Million
-724,464 Reduced 81.24%
167,287 $7.33 Million
Q2 2022

Aug 12, 2022
BUY
$46.84 - $59.75 $11.6 Million - $14.7 Million
246,787 Added 38.26%
891,751 $43.8 Million
Q1 2022

May 16, 2022
SELL
$48.09 - $57.79 $24.3 Million - $29.2 Million
-504,673 Reduced 43.9%
644,964 $36.6 Million
Q4 2021

Feb 14, 2022
BUY
$47.19 - $62.68 $44.8 Million - $59.4 Million
948,360 Added 471.17%
1,149,637 $60.3 Million
Q3 2021

Nov 09, 2021
BUY
$56.91 - $67.81 $136,413 - $162,540
2,397 Added 1.21%
201,277 $12 Million
Q2 2021

Aug 13, 2021
SELL
$64.02 - $71.72 $312,033 - $349,563
-4,874 Reduced 2.39%
198,880 $13.5 Million
Q1 2021

May 13, 2021
BUY
$53.26 - $68.08 $2.51 Million - $3.2 Million
47,057 Added 30.03%
203,754 $13.4 Million
Q4 2020

Feb 11, 2021
SELL
$43.41 - $56.51 $15.6 Million - $20.3 Million
-359,497 Reduced 69.64%
156,697 $8.83 Million
Q3 2020

Nov 12, 2020
BUY
$47.43 - $60.75 $18.5 Million - $23.7 Million
390,503 Added 310.68%
516,194 $25.1 Million
Q2 2020

Aug 12, 2020
BUY
$43.51 - $66.59 $3.51 Million - $5.37 Million
80,580 Added 178.63%
125,691 $7 Million
Q1 2020

May 13, 2020
SELL
$32.82 - $81.13 $1.08 Million - $2.68 Million
-32,974 Reduced 42.23%
45,111 $2.28 Million
Q4 2019

Feb 10, 2020
BUY
$60.96 - $77.7 $1.92 Million - $2.45 Million
31,569 Added 67.87%
78,085 $6.04 Million
Q3 2019

Nov 14, 2019
SELL
$55.78 - $68.08 $992,995 - $1.21 Million
-17,802 Reduced 27.68%
46,516 $2.95 Million
Q2 2019

Aug 14, 2019
BUY
$53.69 - $65.47 $723,204 - $881,880
13,470 Added 26.49%
64,318 $3.76 Million
Q1 2019

May 15, 2019
SELL
$44.53 - $58.9 $1.75 Million - $2.31 Million
-39,262 Reduced 43.57%
50,848 $2.89 Million
Q4 2018

Feb 14, 2019
BUY
$47.64 - $71.26 $2.12 Million - $3.16 Million
44,404 Added 97.15%
90,110 $4.47 Million
Q3 2018

Nov 14, 2018
BUY
$52.03 - $71.41 $47,139 - $64,697
906 Added 2.02%
45,706 $3.24 Million
Q2 2018

Aug 14, 2018
BUY
$48.15 - $56.68 $263,910 - $310,663
5,481 Added 13.94%
44,800 $2.34 Million
Q1 2018

May 15, 2018
SELL
$46.03 - $61.28 $755,260 - $1.01 Million
-16,408 Reduced 29.44%
39,319 $2.05 Million
Q4 2017

Feb 14, 2018
SELL
$50.58 - $60.79 $3.12 Million - $3.75 Million
-61,614 Reduced 52.51%
55,727 $3.26 Million
Q3 2017

Nov 14, 2017
BUY
$53.54 - $68.0 $6.28 Million - $7.98 Million
117,341
117,341 $6.51 Million

Others Institutions Holding NUVA

# of Institutions
9
Shares Held
116K
Call Options Held
0
Put Options Held
0
View Full List

About NUVASIVE INC

NUVA Quotes by TradingView
  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email